The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
The settlement resolved two alleged kickback schemes: Medicare Cost-Sharing Scheme and Copay Assistance Foundations First, Teva has agreed to resolve allegations in a complaint the United States ...
Teva Pharmaceuticals has agreed to pay $450m to settle allegations that it violated several government acts and a raft of kickback allegations. On two serious occasions, it was alleged that Teva ...
Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...
The results excluded more than $1.2 billion of one-time costs including a legal settlement and a goodwill impairment for its API business, for which Teva said it would complete a divestment in the ...
South Dakota will receive almost $300,000 as part of a settlement with global health company Apotex and Teva Pharmaceuticals ...
TEVA) has agreed to a $450 million settlement with the U.S. government to resolve allegations that they violated the Anti-Kickback Statute (AKS) and the False Claims Act (FCA). The settlement ...